Member access

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

PTC Therapeutics Inc. : PTC THERAPEUTICS PRICES INITIAL PUBLIC OFFERING

06/21/2013 | 05:03am US/Eastern

SOUTH PLAINFIELD, NJ - June 20, 2013 - PTC Therapeutics, Inc. (PTC) today announced the pricing of its initial public offering of 8,372,000 shares of common stock at a public offering price of $15.00 per share, before underwriting discounts. All of the shares in the offering are being sold by PTC. In addition, the underwriters have an option for a period of 30 days to purchase up to 1,255,800 additional shares of common stock from PTC at the public offering price, less the underwriting discount. PTC's common stock has been approved for listing on the NASDAQ Global Select Market and is expected to begin trading under the ticker symbol "PTCT" on June 20, 2013.

J.P. Morgan and Credit Suisse are acting as joint book-running managers for the offering. Cowen and Company is acting as co-lead manager and Wedbush PacGrow Life Sciences as co-manager.

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on June 19, 2013.

The offering is being made only by means of a prospectus, copies of which may be obtained from J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717; telephone: 866-803-9204; or Credit Suisse Securities (USA) LLC, Attn: Prospectus Department, One Madison Avenue, New York, NY 10010; telephone: 800-221-1037; email: newyork.prospectus@credit-suisse.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or jurisdiction.

ABOUT PTC THERAPEUTICS, INC.

PTC is a biopharmaceutical company focused on the discovery and development of orally administered small-molecule drugs that target post-transcriptional control processes. Post-transcriptional control processes regulate the rate and timing of protein production and are of central importance to proper cellular function. PTC's internally discovered pipeline addresses multiple therapeutic areas, including rare genetic disorders and infectious diseases.

CONTACT

Jane Baj

PTC Therapeutics, Inc.

908-912-9167

jbaj@ptcbio.com

Sheryl Seapy

Pure Communications

sheryl@purecommunicationsinc.com


distributed by
React to this article
Latest news
Date Title
03:30p CANADIAN MINING : Share Consolidation
03:30p CANADIAN MINING : Signs letter of support for nserc strategic project grant application
03:19p RENTRAK : Announces Official Worldwide Box Office Results for Weekend of March 29, 2015
03:18p AT&T : service restored in some areas
03:17p HYUNDAI HCN : USC film student remains critical, train operator at home following Metro crash
03:15pDJHome' Sweeps Away Box Office
03:07p INTEL : AFA cadets working on system to stop computers viruses before they infect
02:59p DP WORLD : Dubai gov t sets up firm to develop ports around world
02:47p BEST BUY : Tractor Supply latest business to build on FM 365
02:42p ADA : UF Health Cancer Center gets state award
Latest news
Advertisement
Hot News 
JUDGES SCIENTIFIC : Profit Up But Like-For-Like Revenue Shrinks
MELROSE BANCORP : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
OHR PHARMACEUTICAL : Announces Final Topline Data From OHR-102 Phase II IMPACT Study in Wet-AMD
ANDREWS SYKES : Temporary arena in London requires replacement heating
RBC BEARINGS : Nasdaq stocks posting largest percentage increases
Most Read News
03/28 OGE ENERGY : BRIEF: More than 3,000 without power in NW Oklahoma City
03/28 F SECURE : Hypponen Reviews the State of the Internet
03/28 A BROWN : Voter's guide
03/28 ST JUDE MEDICAL : . Jude launches trial of heart valve for children
03/28 PG&E6CPREF : PG&E helps Salvation Army with mobile vehicle
Most recommended articles
03:15pDJHome' Sweeps Away Box Office
02:07p Stocks likely to drift as investors await Fed, earnings
01:50p Euro Relief Rally May Hit Wall as Market Refocuses on EZ CPI, US NFPs
01:16p ABN Amro IPO back in sight after executives concede on pay
01:14p ABN Amro IPO back in sight after executives concede on pay
Dynamic quotes  
ON
| OFF